蕲蛇酶注射液治疗中枢性眩晕的临床观察  

The clinical observation of Acutobin injection on the treatment of central vertigo

作　　者：孙辉[1] 朱晓峰[1] 张腾腾[1] 

机构地区：[1]佳木斯大学神经病学研究所,黑龙江佳木斯154007

出　　处：《黑龙江医药科学》2016年第6期52-53,共2页Heilongjiang Medicine and Pharmacy

基　　金：黑龙江省教育厅科学技术研究项目;编号:12521543

摘　　要：目的:评价蕲蛇酶注射液应用于中枢性眩晕患者的疗效。方法:将94例住院病人编号,按随机数字表随机分为治疗组与对照组,治疗组应用蕲蛇酶注射液静脉滴注治疗,对照组患者应用疏血通注射液滴注治疗,疗效均在应用药物10d后进行评定,待实验结束后比较两组药物各自疗效,统计分析所得数据。结果:蕲蛇酶注射液治疗后有效率为91.5%,疏血通注射液治疗后有效率为72.3%,经χ2检验,差异具有统计学意义(P<0.05)。结论:蕲蛇酶注射液应用于中枢性眩晕可取得较为满意的效果。Objective： To evaluate the effect of Acutobin injection for patients with central vertigo. Methods： 94 hospitalized patients were randomly divided into treatment group and control group. Patients in treatment group are treated with Acutobin injection, while those in control group are treated with Shuxuetong injection. The efficacy is assessed in ten days. At the end of the experiment, the treatment effects of the two groups are compared, and the dates are statisticly analyzed. Results： The effective rate after the treatment with Acutobin Injection is 91.5%, and that with Shnxuetong injection is 72.3%. The results of X2 test showed that （P 〈 0. 05）, so the difference has statistical significance. Conclusions： Acutase injection applied to central vertigo can achieve satisfactory results.

关 键 词：蕲蛇酶注射液 疏血通注射液 中枢性眩晕 

分 类 号：R441.2[医药卫生—诊断学]